HIMS Stock Hits New ATH After Successful Super Bowl Ad
Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth ...
These were the 5 worst-performing stocks in the Nasdaq-100 in January 2025
Although most stocks made forward progress in January, a few of them bucked the bigger trend for understandable reasons.
3 Fabulous Dividend Stocks to Buy in February
AbbVie is a resurging Dividend King. Amgen's recent clinical setback makes its stock available at a discount. Gilead Sciences ...
Palantir Technologies Surges to $100: Is This Red-Hot AI Stock Still a Buy? 3 Analysts Weigh In.
The stock's ascension from $6 to over $100 in just over two years is one of Wall Street's most incredible hot streaks.
These 2 AI Stocks Are Vying to Be the Next Palantir. Are Either of Them Buys?
The platform accelerates the power and utility of Palantir's software suite, allowing users to easily find and organize the ...
How to boost your chances of positive returns in the stock market
Looking to increase your odds of success in the S&P/ASX 200 Index (ASX: XJO) and global stock markets? Here’s how to go about ...
Day One Biopharmaceuticals: A Successful Launch In Pediatric Cancer
Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...
How to Pick Stocks: 5 Things All Beginner Investors Should Know
There are two primary strategies investors use to research stocks: fundamental analysis and technical analysis. "Typically, ...
Investopedia on MSN15d
Can Investing in Dividend Stocks Make You a Millionaire?
Discover how dividend investing, combined with time and compounding growth, can build seven-figure wealth, and learn the proven strategies that separate successful dividend investors from those who ...
Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'
A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock. The post Up 135% in a year ...
The stock fund manager who holds America's record of annual outperformance shares 2 bargain trades he's making in an expensive market
David Giroux has beaten his Morningstar peer group for the last 17 years. Here's how he's planning to keep the streak in 2025 ...
Loews: At $87 It's Undervalued Given Management's Persistent History Of Success
Loews Corporation stays undervalued with expert asset allocation, a strong balance sheet, and $3.3B in reserves. Click for my ...